

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 7.38159440 |
| 2 | urate metabolic process (GO:0046415) | 7.22433623 |
| 3 | lysine catabolic process (GO:0006554) | 6.70053882 |
| 4 | lysine metabolic process (GO:0006553) | 6.70053882 |
| 5 | cysteine metabolic process (GO:0006534) | 6.68805268 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 6.59691916 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.59691916 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 6.47192887 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.47192887 |
| 10 | glyoxylate metabolic process (GO:0046487) | 6.42073841 |
| 11 | drug transport (GO:0015893) | 6.17739860 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 5.83687594 |
| 13 | drug catabolic process (GO:0042737) | 5.60807330 |
| 14 | organic cation transport (GO:0015695) | 5.50846654 |
| 15 | phosphate ion transport (GO:0006817) | 5.40914256 |
| 16 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.29295600 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 5.18069714 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 5.18069714 |
| 19 | tryptophan catabolic process (GO:0006569) | 5.18069714 |
| 20 | exogenous drug catabolic process (GO:0042738) | 5.08475378 |
| 21 | homocysteine metabolic process (GO:0050667) | 5.05767640 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.01774509 |
| 23 | tryptophan metabolic process (GO:0006568) | 4.98745455 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.94964540 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 4.86342477 |
| 26 | phosphate ion transmembrane transport (GO:0035435) | 4.67788034 |
| 27 | aspartate family amino acid catabolic process (GO:0009068) | 4.67736633 |
| 28 | response to mercury ion (GO:0046689) | 4.66851046 |
| 29 | cellular modified amino acid catabolic process (GO:0042219) | 4.63562302 |
| 30 | tricarboxylic acid metabolic process (GO:0072350) | 4.60685747 |
| 31 | kynurenine metabolic process (GO:0070189) | 4.57729206 |
| 32 | short-chain fatty acid metabolic process (GO:0046459) | 4.56396084 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.53896614 |
| 34 | serine family amino acid metabolic process (GO:0009069) | 4.45714705 |
| 35 | quaternary ammonium group transport (GO:0015697) | 4.43034441 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.29701054 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 4.26940420 |
| 38 | valine metabolic process (GO:0006573) | 4.26135178 |
| 39 | regulation of cholesterol homeostasis (GO:2000188) | 4.21526089 |
| 40 | cellular ketone body metabolic process (GO:0046950) | 4.17290501 |
| 41 | branched-chain amino acid metabolic process (GO:0009081) | 4.15158712 |
| 42 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.15076264 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 4.09533626 |
| 44 | sulfation (GO:0051923) | 4.08733288 |
| 45 | fatty acid beta-oxidation (GO:0006635) | 4.06942820 |
| 46 | cellular amino acid catabolic process (GO:0009063) | 4.06547548 |
| 47 | bile acid biosynthetic process (GO:0006699) | 4.04970561 |
| 48 | glutamate metabolic process (GO:0006536) | 4.01496897 |
| 49 | proline metabolic process (GO:0006560) | 3.97532378 |
| 50 | 2-oxoglutarate metabolic process (GO:0006103) | 3.96840482 |
| 51 | transepithelial transport (GO:0070633) | 3.93665163 |
| 52 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.92330935 |
| 53 | serine family amino acid biosynthetic process (GO:0009070) | 3.89604934 |
| 54 | fatty acid oxidation (GO:0019395) | 3.89174022 |
| 55 | reverse cholesterol transport (GO:0043691) | 3.86244330 |
| 56 | renal absorption (GO:0070293) | 3.81339998 |
| 57 | lipid oxidation (GO:0034440) | 3.80257534 |
| 58 | otic vesicle formation (GO:0030916) | 3.79194580 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 3.79184284 |
| 60 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.78373238 |
| 61 | excretion (GO:0007588) | 3.69948835 |
| 62 | vitamin D metabolic process (GO:0042359) | 3.68963584 |
| 63 | drug metabolic process (GO:0017144) | 3.66084407 |
| 64 | carboxylic acid catabolic process (GO:0046395) | 3.64720392 |
| 65 | organic acid catabolic process (GO:0016054) | 3.64720392 |
| 66 | branched-chain amino acid catabolic process (GO:0009083) | 3.64280082 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 3.63808508 |
| 68 | fatty acid catabolic process (GO:0009062) | 3.62242002 |
| 69 | * regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.61019852 |
| 70 | acetyl-CoA metabolic process (GO:0006084) | 3.60688708 |
| 71 | alpha-linolenic acid metabolic process (GO:0036109) | 3.58869018 |
| 72 | carnitine metabolic process (GO:0009437) | 3.57952596 |
| 73 | ketone body metabolic process (GO:1902224) | 3.56234839 |
| 74 | glutathione biosynthetic process (GO:0006750) | 3.55425037 |
| 75 | regulation of bile acid biosynthetic process (GO:0070857) | 3.55357261 |
| 76 | monocarboxylic acid catabolic process (GO:0072329) | 3.52954922 |
| 77 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.49752128 |
| 78 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.49752128 |
| 79 | amino-acid betaine transport (GO:0015838) | 3.47185656 |
| 80 | carnitine transport (GO:0015879) | 3.47185656 |
| 81 | bile acid metabolic process (GO:0008206) | 3.46691055 |
| 82 | phospholipid efflux (GO:0033700) | 3.45871276 |
| 83 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.44460614 |
| 84 | tyrosine metabolic process (GO:0006570) | 3.42071715 |
| 85 | urea cycle (GO:0000050) | 3.40937086 |
| 86 | urea metabolic process (GO:0019627) | 3.40937086 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 3.40567814 |
| 88 | regulation of cholesterol esterification (GO:0010872) | 3.39604556 |
| 89 | peptide catabolic process (GO:0043171) | 3.37974103 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.33332452 |
| 91 | fructose metabolic process (GO:0006000) | 3.32778482 |
| 92 | cellular biogenic amine catabolic process (GO:0042402) | 3.31792964 |
| 93 | amine catabolic process (GO:0009310) | 3.31792964 |
| 94 | phosphate ion homeostasis (GO:0055062) | 3.28524458 |
| 95 | trivalent inorganic anion homeostasis (GO:0072506) | 3.28524458 |
| 96 | flavonoid metabolic process (GO:0009812) | 3.27553027 |
| 97 | cellular glucuronidation (GO:0052695) | 3.23848708 |
| 98 | glucuronate metabolic process (GO:0019585) | 3.23249401 |
| 99 | uronic acid metabolic process (GO:0006063) | 3.23249401 |
| 100 | auditory receptor cell differentiation (GO:0042491) | 3.22744521 |
| 101 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.22258987 |
| 102 | nitrogen cycle metabolic process (GO:0071941) | 3.21298971 |
| 103 | negative regulation of sterol transport (GO:0032372) | 3.21205480 |
| 104 | negative regulation of cholesterol transport (GO:0032375) | 3.21205480 |
| 105 | intestinal cholesterol absorption (GO:0030299) | 3.21052129 |
| 106 | intestinal absorption (GO:0050892) | 3.20290920 |
| 107 | glutathione derivative metabolic process (GO:1901685) | 3.20169542 |
| 108 | glutathione derivative biosynthetic process (GO:1901687) | 3.20169542 |
| 109 | triglyceride homeostasis (GO:0070328) | 3.19825457 |
| 110 | acylglycerol homeostasis (GO:0055090) | 3.19825457 |
| 111 | 4-hydroxyproline metabolic process (GO:0019471) | 3.19799520 |
| 112 | toxin transport (GO:1901998) | 3.18616770 |
| 113 | metanephric nephron tubule development (GO:0072234) | 3.17902127 |
| 114 | metanephric tubule development (GO:0072170) | 3.17902127 |
| 115 | protein carboxylation (GO:0018214) | 3.15836988 |
| 116 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.15836988 |
| 117 | ethanol oxidation (GO:0006069) | 3.14001499 |
| 118 | indole-containing compound metabolic process (GO:0042430) | 3.13713385 |
| 119 | glycine metabolic process (GO:0006544) | 3.12993093 |
| 120 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.11803211 |
| 121 | protein K11-linked deubiquitination (GO:0035871) | 3.10110554 |
| 122 | coenzyme catabolic process (GO:0009109) | 3.09977304 |
| 123 | response to growth hormone (GO:0060416) | 3.09890946 |
| 124 | cytidine metabolic process (GO:0046087) | 3.09817101 |
| 125 | cytidine catabolic process (GO:0006216) | 3.09817101 |
| 126 | cytidine deamination (GO:0009972) | 3.09817101 |
| 127 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.07090156 |
| 128 | protein-lipid complex remodeling (GO:0034368) | 3.03986940 |
| 129 | macromolecular complex remodeling (GO:0034367) | 3.03986940 |
| 130 | plasma lipoprotein particle remodeling (GO:0034369) | 3.03986940 |
| 131 | cobalamin metabolic process (GO:0009235) | 3.01988519 |
| 132 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.96101438 |
| 133 | basic amino acid transport (GO:0015802) | 2.95923492 |
| 134 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.90461110 |
| 135 | phospholipid homeostasis (GO:0055091) | 2.88796230 |
| 136 | * endocrine pancreas development (GO:0031018) | 2.88676826 |
| 137 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.87544420 |
| 138 | protein-lipid complex assembly (GO:0065005) | 2.84532836 |
| 139 | regulation of glomerulus development (GO:0090192) | 2.84507376 |
| 140 | regulation of alkaline phosphatase activity (GO:0010692) | 2.84161602 |
| 141 | positive regulation of digestive system process (GO:0060456) | 2.82045519 |
| 142 | regulation of glucokinase activity (GO:0033131) | 2.80552921 |
| 143 | regulation of hexokinase activity (GO:1903299) | 2.80552921 |
| 144 | cholesterol efflux (GO:0033344) | 2.79802358 |
| 145 | L-ascorbic acid metabolic process (GO:0019852) | 2.77006493 |
| 146 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.75800277 |
| 147 | cellular response to ATP (GO:0071318) | 2.73406616 |
| 148 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.72100156 |
| 149 | regulation of hippo signaling (GO:0035330) | 2.71940466 |
| 150 | xenobiotic catabolic process (GO:0042178) | 2.65609600 |
| 151 | metanephric nephron epithelium development (GO:0072243) | 2.65590956 |
| 152 | positive regulation of glomerulus development (GO:0090193) | 2.64685077 |
| 153 | regulation of digestive system process (GO:0044058) | 2.61886029 |
| 154 | ethanol metabolic process (GO:0006067) | 2.57916201 |
| 155 | positive regulation of metanephros development (GO:0072216) | 2.57266917 |
| 156 | positive regulation of icosanoid secretion (GO:0032305) | 2.56325853 |
| 157 | heme transport (GO:0015886) | 2.55551938 |
| 158 | regulation of triglyceride catabolic process (GO:0010896) | 2.54257933 |
| 159 | plasma lipoprotein particle organization (GO:0071827) | 2.53976044 |
| 160 | regulation of protein activation cascade (GO:2000257) | 2.53717499 |
| 161 | epoxygenase P450 pathway (GO:0019373) | 2.53651177 |
| 162 | metanephric epithelium development (GO:0072207) | 2.52374025 |
| 163 | negative regulation of coagulation (GO:0050819) | 2.51807420 |
| 164 | cholesterol homeostasis (GO:0042632) | 2.51408228 |
| 165 | cholesterol transport (GO:0030301) | 2.51405358 |
| 166 | sterol transport (GO:0015918) | 2.51405358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.94561189 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.75407515 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.02077577 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.25783699 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.07550706 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.05921337 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.63655049 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.24739606 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.04759551 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.77517302 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.63656598 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.58132915 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.37658482 |
| 14 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.34499171 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31134411 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28718478 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.11262616 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.10455356 |
| 19 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.02987400 |
| 20 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.01247460 |
| 21 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.96309418 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.91575914 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.85226855 |
| 24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.82497171 |
| 25 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.82351908 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.78070662 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.72749081 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.71197806 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.70877916 |
| 30 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.70192521 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66235381 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65420842 |
| 33 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.64644478 |
| 34 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.61659007 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60120327 |
| 36 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.59361035 |
| 37 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.58705660 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.54688768 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.51853180 |
| 40 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.49197284 |
| 41 | TP53_16413492_ChIP-PET_HCT116_Human | 1.47445623 |
| 42 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.46181990 |
| 43 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.41078199 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40363836 |
| 45 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.39629613 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39500244 |
| 47 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39245637 |
| 48 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35373587 |
| 49 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.35269945 |
| 50 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.34399865 |
| 51 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32829795 |
| 52 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.30366349 |
| 53 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.29578605 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.27450865 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27378389 |
| 56 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.26626826 |
| 57 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.26626826 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24931633 |
| 59 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.23480642 |
| 60 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23367478 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23232746 |
| 62 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.22196325 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21695342 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20123866 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17527204 |
| 66 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17371722 |
| 67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16449360 |
| 68 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.16235425 |
| 69 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.15522632 |
| 70 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.15487122 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13895180 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13862589 |
| 73 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13653558 |
| 74 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13261674 |
| 75 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.13232840 |
| 76 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13156916 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12652310 |
| 78 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11071400 |
| 79 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09422893 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09221724 |
| 81 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08993419 |
| 82 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.07775344 |
| 83 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05807802 |
| 84 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.05382793 |
| 85 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05329645 |
| 86 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05329645 |
| 87 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04708431 |
| 88 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.04255039 |
| 89 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.03938149 |
| 90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03210889 |
| 91 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03138294 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03023132 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02680863 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.01379986 |
| 95 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.98578661 |
| 96 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98578661 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97584063 |
| 98 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97100112 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96996039 |
| 100 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96351683 |
| 101 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96337786 |
| 102 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.95118461 |
| 103 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95117382 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95069231 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94149196 |
| 106 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94080161 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93094397 |
| 108 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.91542750 |
| 109 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.91407301 |
| 110 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90965561 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90758355 |
| 112 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90684965 |
| 113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90204170 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90204170 |
| 115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89643390 |
| 116 | ATF3_27146783_Chip-Seq_COLON_Human | 0.85289634 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84114599 |
| 118 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.82859028 |
| 119 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80588053 |
| 120 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79965496 |
| 121 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.79350655 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76280066 |
| 123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73911346 |
| 124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71872809 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71819393 |
| 126 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71625704 |
| 127 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.70517877 |
| 128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.70126868 |
| 129 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.70099554 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69435125 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.68932448 |
| 132 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.68734245 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68656620 |
| 134 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67296627 |
| 135 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.67220764 |
| 136 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.66894013 |
| 137 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65950934 |
| 138 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.64839953 |
| 139 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64196076 |
| 140 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63952415 |
| 141 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.63629517 |
| 142 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.63369183 |
| 143 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.62549960 |
| 144 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.62391665 |
| 145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61713591 |
| 146 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.61655964 |
| 147 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.61125244 |
| 148 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.60690706 |
| 149 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60584111 |
| 150 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.58159447 |
| 151 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.58058757 |
| 152 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.57560766 |
| 153 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.57560766 |
| 154 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.57015147 |
| 155 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.55893279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.97093671 |
| 2 | MP0005365_abnormal_bile_salt | 4.91959018 |
| 3 | * MP0002139_abnormal_hepatobiliary_system | 4.90744530 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.63860155 |
| 5 | MP0003252_abnormal_bile_duct | 4.33990252 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.83999178 |
| 7 | MP0005332_abnormal_amino_acid | 3.79862546 |
| 8 | MP0003195_calcinosis | 3.76386869 |
| 9 | MP0004043_abnormal_pH_regulation | 3.75124082 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 3.64025265 |
| 11 | MP0003183_abnormal_peptide_metabolism | 3.49980205 |
| 12 | MP0002163_abnormal_gland_morphology | 3.34909010 |
| 13 | MP0005083_abnormal_biliary_tract | 3.25689563 |
| 14 | MP0009643_abnormal_urine_homeostasis | 3.05317555 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.93899686 |
| 16 | * MP0002138_abnormal_hepatobiliary_system | 2.92409125 |
| 17 | MP0008872_abnormal_physiological_respon | 2.47315960 |
| 18 | MP0001765_abnormal_ion_homeostasis | 2.42492194 |
| 19 | MP0005379_endocrine/exocrine_gland_phen | 2.36002580 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.28979615 |
| 21 | MP0005636_abnormal_mineral_homeostasis | 2.28058813 |
| 22 | MP0001756_abnormal_urination | 2.25516131 |
| 23 | MP0005220_abnormal_exocrine_pancreas | 2.17327897 |
| 24 | * MP0002928_abnormal_bile_duct | 2.11950050 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.03422507 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.96037967 |
| 27 | MP0002136_abnormal_kidney_physiology | 1.94499922 |
| 28 | MP0002132_abnormal_respiratory_system | 1.83654646 |
| 29 | * MP0005084_abnormal_gallbladder_morpholo | 1.83067297 |
| 30 | MP0002254_reproductive_system_inflammat | 1.70357331 |
| 31 | MP0004264_abnormal_extraembryonic_tissu | 1.70060323 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.69860722 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.65719990 |
| 34 | MP0002277_abnormal_respiratory_mucosa | 1.60216205 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.56020992 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.55480723 |
| 37 | MP0010678_abnormal_skin_adnexa | 1.55322625 |
| 38 | MP0000613_abnormal_salivary_gland | 1.49290258 |
| 39 | * MP0002118_abnormal_lipid_homeostasis | 1.46836359 |
| 40 | MP0003283_abnormal_digestive_organ | 1.44033737 |
| 41 | MP0003868_abnormal_feces_composition | 1.41612978 |
| 42 | MP0000538_abnormal_urinary_bladder | 1.41058201 |
| 43 | * MP0000609_abnormal_liver_physiology | 1.37866557 |
| 44 | MP0003186_abnormal_redox_activity | 1.37342173 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33691096 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.26180923 |
| 47 | MP0009840_abnormal_foam_cell | 1.25308223 |
| 48 | MP0001873_stomach_inflammation | 1.23652459 |
| 49 | MP0001944_abnormal_pancreas_morphology | 1.22830993 |
| 50 | MP0005377_hearing/vestibular/ear_phenot | 1.20067760 |
| 51 | MP0003878_abnormal_ear_physiology | 1.20067760 |
| 52 | MP0001958_emphysema | 1.19416573 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.18698793 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.14598725 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.12559676 |
| 56 | MP0000685_abnormal_immune_system | 1.11956188 |
| 57 | MP0001764_abnormal_homeostasis | 1.09823166 |
| 58 | MP0002168_other_aberrant_phenotype | 1.09522106 |
| 59 | MP0000003_abnormal_adipose_tissue | 1.09491578 |
| 60 | MP0000566_synostosis | 1.07021908 |
| 61 | MP0000383_abnormal_hair_follicle | 1.06370103 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 1.01242242 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 0.97553678 |
| 64 | MP0005451_abnormal_body_composition | 0.97347177 |
| 65 | MP0005310_abnormal_salivary_gland | 0.96899112 |
| 66 | MP0004133_heterotaxia | 0.95109936 |
| 67 | MP0003943_abnormal_hepatobiliary_system | 0.94596028 |
| 68 | MP0005408_hypopigmentation | 0.94579741 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 0.93048930 |
| 70 | * MP0000598_abnormal_liver_morphology | 0.93039921 |
| 71 | MP0002135_abnormal_kidney_morphology | 0.92505175 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 0.89252952 |
| 73 | * MP0009642_abnormal_blood_homeostasis | 0.84820577 |
| 74 | MP0002166_altered_tumor_susceptibility | 0.84791317 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 0.83536487 |
| 76 | MP0003879_abnormal_hair_cell | 0.83138858 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.82662614 |
| 78 | MP0001485_abnormal_pinna_reflex | 0.82154525 |
| 79 | MP0002896_abnormal_bone_mineralization | 0.81886497 |
| 80 | MP0000639_abnormal_adrenal_gland | 0.80616722 |
| 81 | MP0005670_abnormal_white_adipose | 0.80434462 |
| 82 | MP0000516_abnormal_urinary_system | 0.80429365 |
| 83 | MP0005367_renal/urinary_system_phenotyp | 0.80429365 |
| 84 | MP0004272_abnormal_basement_membrane | 0.78863106 |
| 85 | MP0003938_abnormal_ear_development | 0.78634910 |
| 86 | MP0001348_abnormal_lacrimal_gland | 0.77696158 |
| 87 | MP0000372_irregular_coat_pigmentation | 0.77517250 |
| 88 | MP0005410_abnormal_fertilization | 0.77415022 |
| 89 | MP0002006_tumorigenesis | 0.76995548 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.75340688 |
| 91 | MP0002796_impaired_skin_barrier | 0.70165379 |
| 92 | MP0003638_abnormal_response/metabolism_ | 0.69240099 |
| 93 | MP0003959_abnormal_lean_body | 0.68143753 |
| 94 | MP0005395_other_phenotype | 0.66186101 |
| 95 | MP0000477_abnormal_intestine_morphology | 0.64751061 |
| 96 | MP0003953_abnormal_hormone_level | 0.64617648 |
| 97 | MP0005535_abnormal_body_temperature | 0.64341797 |
| 98 | MP0000678_abnormal_parathyroid_gland | 0.63369684 |
| 99 | MP0003724_increased_susceptibility_to | 0.62474168 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.62064643 |
| 101 | MP0001661_extended_life_span | 0.59931674 |
| 102 | MP0000631_abnormal_neuroendocrine_gland | 0.59418472 |
| 103 | MP0009764_decreased_sensitivity_to | 0.58828743 |
| 104 | MP0000462_abnormal_digestive_system | 0.58819004 |
| 105 | MP0008469_abnormal_protein_level | 0.58626606 |
| 106 | MP0002160_abnormal_reproductive_system | 0.58416654 |
| 107 | MP0004134_abnormal_chest_morphology | 0.57854226 |
| 108 | MP0008004_abnormal_stomach_pH | 0.57786622 |
| 109 | MP0009384_cardiac_valve_regurgitation | 0.57583762 |
| 110 | MP0005389_reproductive_system_phenotype | 0.57566575 |
| 111 | MP0003329_amyloid_beta_deposits | 0.56821388 |
| 112 | MP0009672_abnormal_birth_weight | 0.56632520 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.56584988 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.56307868 |
| 115 | MP0001849_ear_inflammation | 0.56238231 |
| 116 | MP0006054_spinal_hemorrhage | 0.54705416 |
| 117 | MP0003936_abnormal_reproductive_system | 0.54038759 |
| 118 | MP0004782_abnormal_surfactant_physiolog | 0.53863441 |
| 119 | MP0001790_abnormal_immune_system | 0.52765175 |
| 120 | MP0005387_immune_system_phenotype | 0.52765175 |
| 121 | MP0000534_abnormal_ureter_morphology | 0.52589911 |
| 122 | MP0010368_abnormal_lymphatic_system | 0.52479114 |
| 123 | MP0001984_abnormal_olfaction | 0.51483006 |
| 124 | MP0002098_abnormal_vibrissa_morphology | 0.50171315 |
| 125 | MP0000604_amyloidosis | 0.49279286 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.48678795 |
| 127 | MP0001664_abnormal_digestion | 0.48652809 |
| 128 | MP0004885_abnormal_endolymph | 0.42532197 |
| 129 | MP0000537_abnormal_urethra_morphology | 0.41499719 |
| 130 | MP0005501_abnormal_skin_physiology | 0.40176509 |
| 131 | MP0000013_abnormal_adipose_tissue | 0.39247692 |
| 132 | MP0005375_adipose_tissue_phenotype | 0.38509367 |
| 133 | MP0005647_abnormal_sex_gland | 0.37597476 |
| 134 | MP0003942_abnormal_urinary_system | 0.37010424 |
| 135 | MP0009763_increased_sensitivity_to | 0.36810570 |
| 136 | MP0003045_fibrosis | 0.36720734 |
| 137 | MP0001270_distended_abdomen | 0.36676341 |
| 138 | MP0002089_abnormal_postnatal_growth/wei | 0.36052428 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.35862791 |
| 140 | MP0003566_abnormal_cell_adhesion | 0.34638899 |
| 141 | MP0005376_homeostasis/metabolism_phenot | 0.34293219 |
| 142 | MP0002909_abnormal_adrenal_gland | 0.34188760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Gout (HP:0001997) | 5.52258010 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 5.09234973 |
| 3 | Increased circulating renin level (HP:0000848) | 5.03477840 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 5.01808568 |
| 5 | Metabolic alkalosis (HP:0200114) | 4.89405931 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.87406262 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 4.75222240 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.67838738 |
| 9 | Hyperglycinuria (HP:0003108) | 4.54194368 |
| 10 | Hypomagnesemia (HP:0002917) | 4.49808430 |
| 11 | Proximal tubulopathy (HP:0000114) | 4.43863693 |
| 12 | Polyuria (HP:0000103) | 4.40778395 |
| 13 | Ketoacidosis (HP:0001993) | 4.39662289 |
| 14 | Abnormal urine output (HP:0012590) | 4.33348911 |
| 15 | Abnormality of renal excretion (HP:0011036) | 4.33107458 |
| 16 | Ketosis (HP:0001946) | 4.21917285 |
| 17 | * Abnormality of purine metabolism (HP:0004352) | 4.11110400 |
| 18 | Alkalosis (HP:0001948) | 4.03830486 |
| 19 | Generalized aminoaciduria (HP:0002909) | 3.97829597 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.92372096 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 3.92372096 |
| 22 | Abnormality of magnesium homeostasis (HP:0004921) | 3.84235808 |
| 23 | Intrahepatic cholestasis (HP:0001406) | 3.82871330 |
| 24 | * Hyperuricemia (HP:0002149) | 3.78093724 |
| 25 | * Increased purine levels (HP:0004368) | 3.78093724 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.76111668 |
| 27 | Pigmentary retinal degeneration (HP:0001146) | 3.74921971 |
| 28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.54405387 |
| 29 | Abnormality of renin-angiotensin system (HP:0000847) | 3.53439344 |
| 30 | Renal salt wasting (HP:0000127) | 3.51731022 |
| 31 | Abnormal drinking behavior (HP:0030082) | 3.46158005 |
| 32 | Polydipsia (HP:0001959) | 3.46158005 |
| 33 | Enlarged kidneys (HP:0000105) | 3.43067364 |
| 34 | Tubular atrophy (HP:0000092) | 3.42375497 |
| 35 | Facial shape deformation (HP:0011334) | 3.40278106 |
| 36 | Potter facies (HP:0002009) | 3.40278106 |
| 37 | Hyperglycinemia (HP:0002154) | 3.38337157 |
| 38 | Hyperammonemia (HP:0001987) | 3.33365135 |
| 39 | Tetany (HP:0001281) | 3.31130429 |
| 40 | * Abnormality of nucleobase metabolism (HP:0010932) | 3.30798892 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.26835868 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.24776453 |
| 43 | Xanthomatosis (HP:0000991) | 3.23400070 |
| 44 | Hyperaldosteronism (HP:0000859) | 3.21044705 |
| 45 | Congenital sensorineural hearing impairment (HP:0008527) | 3.20663184 |
| 46 | Hypothermia (HP:0002045) | 3.13290194 |
| 47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.07475405 |
| 48 | Abnormality of the nasal septum (HP:0000419) | 3.06810388 |
| 49 | * Glycosuria (HP:0003076) | 2.98361524 |
| 50 | * Abnormality of urine glucose concentration (HP:0011016) | 2.98361524 |
| 51 | * Abnormal pancreas size (HP:0012094) | 2.97841372 |
| 52 | Vascular calcification (HP:0004934) | 2.95691023 |
| 53 | Renal tubular acidosis (HP:0001947) | 2.91595008 |
| 54 | Pancreatic cysts (HP:0001737) | 2.89173099 |
| 55 | Deep venous thrombosis (HP:0002625) | 2.87566597 |
| 56 | Hypokalemia (HP:0002900) | 2.86706247 |
| 57 | Abnormality of vitamin B metabolism (HP:0004340) | 2.86554092 |
| 58 | Abnormality of proline metabolism (HP:0010907) | 2.83012828 |
| 59 | Hydroxyprolinuria (HP:0003080) | 2.83012828 |
| 60 | Delayed CNS myelination (HP:0002188) | 2.80569502 |
| 61 | Hyperphosphaturia (HP:0003109) | 2.78843816 |
| 62 | Decreased circulating renin level (HP:0003351) | 2.76744383 |
| 63 | Hypercalciuria (HP:0002150) | 2.76518281 |
| 64 | Tubulointerstitial fibrosis (HP:0005576) | 2.74667891 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.73086629 |
| 66 | Spontaneous abortion (HP:0005268) | 2.72357250 |
| 67 | Malnutrition (HP:0004395) | 2.72226111 |
| 68 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.70953354 |
| 69 | Dicarboxylic aciduria (HP:0003215) | 2.70953354 |
| 70 | Abnormality of vitamin metabolism (HP:0100508) | 2.69685527 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.66471423 |
| 72 | Azoospermia (HP:0000027) | 2.63161363 |
| 73 | Metabolic acidosis (HP:0001942) | 2.60434570 |
| 74 | Fat malabsorption (HP:0002630) | 2.59808814 |
| 75 | Hypolipoproteinemia (HP:0010981) | 2.58752008 |
| 76 | Symptomatic seizures (HP:0011145) | 2.52469578 |
| 77 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.52306743 |
| 78 | * Nephrolithiasis (HP:0000787) | 2.48904889 |
| 79 | Hypophosphatemia (HP:0002148) | 2.48546947 |
| 80 | Abnormal urine phosphate concentration (HP:0012599) | 2.48032821 |
| 81 | Rickets (HP:0002748) | 2.47956668 |
| 82 | Glomerulosclerosis (HP:0000096) | 2.46543316 |
| 83 | Cystic liver disease (HP:0006706) | 2.45037796 |
| 84 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.44978751 |
| 85 | Hepatocellular carcinoma (HP:0001402) | 2.44320132 |
| 86 | Hypoalphalipoproteinemia (HP:0003233) | 2.44244149 |
| 87 | Vacuolated lymphocytes (HP:0001922) | 2.42005811 |
| 88 | Abnormality of potassium homeostasis (HP:0011042) | 2.41550198 |
| 89 | Dehydration (HP:0001944) | 2.36362049 |
| 90 | Chronic hepatic failure (HP:0100626) | 2.32745968 |
| 91 | Irritability (HP:0000737) | 2.32104455 |
| 92 | Lethargy (HP:0001254) | 2.31933829 |
| 93 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.30954388 |
| 94 | Pendular nystagmus (HP:0012043) | 2.30619730 |
| 95 | Abnormal biliary tract morphology (HP:0012440) | 2.28565638 |
| 96 | Vomiting (HP:0002013) | 2.26603678 |
| 97 | Abnormal tarsal ossification (HP:0008369) | 2.25734390 |
| 98 | Stenosis of the external auditory canal (HP:0000402) | 2.25196894 |
| 99 | Sensorimotor neuropathy (HP:0007141) | 2.25150885 |
| 100 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.25094811 |
| 101 | Chorioretinal atrophy (HP:0000533) | 2.25003019 |
| 102 | Nephrocalcinosis (HP:0000121) | 2.24317534 |
| 103 | * Exocrine pancreatic insufficiency (HP:0001738) | 2.22606082 |
| 104 | Conical tooth (HP:0000698) | 2.20845270 |
| 105 | * Abnormal enzyme/coenzyme activity (HP:0012379) | 2.19749357 |
| 106 | Abnormality of the renal medulla (HP:0100957) | 2.17566033 |
| 107 | Abolished electroretinogram (ERG) (HP:0000550) | 2.16597202 |
| 108 | Hypobetalipoproteinemia (HP:0003563) | 2.16529331 |
| 109 | Widely patent fontanelles and sutures (HP:0004492) | 2.15906785 |
| 110 | Rectal prolapse (HP:0002035) | 2.15447080 |
| 111 | Delayed epiphyseal ossification (HP:0002663) | 2.14067196 |
| 112 | Methylmalonic acidemia (HP:0002912) | 2.10590489 |
| 113 | Severe visual impairment (HP:0001141) | 2.09682295 |
| 114 | Abnormality of the intrinsic pathway (HP:0010989) | 2.08897592 |
| 115 | Ileus (HP:0002595) | 2.08885337 |
| 116 | Abnormality of the common coagulation pathway (HP:0010990) | 2.07833337 |
| 117 | Esophageal varix (HP:0002040) | 2.06102174 |
| 118 | Abnormality of the renal cortex (HP:0011035) | 2.05547696 |
| 119 | Hyperglycemia (HP:0003074) | 2.04768624 |
| 120 | * Abnormality of alkaline phosphatase activity (HP:0004379) | 2.04756622 |
| 121 | Abnormality of serum amino acid levels (HP:0003112) | 2.04420800 |
| 122 | Focal segmental glomerulosclerosis (HP:0000097) | 2.02356028 |
| 123 | Conjugated hyperbilirubinemia (HP:0002908) | 2.01586974 |
| 124 | Prolonged partial thromboplastin time (HP:0003645) | 2.00527716 |
| 125 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.00498117 |
| 126 | Elevated alkaline phosphatase (HP:0003155) | 1.99478250 |
| 127 | Metaphyseal cupping (HP:0003021) | 1.99270952 |
| 128 | Confusion (HP:0001289) | 1.98149589 |
| 129 | Hyperkalemia (HP:0002153) | 1.97223921 |
| 130 | Hypophosphatemic rickets (HP:0004912) | 1.95179196 |
| 131 | Short hallux (HP:0010109) | 1.94214100 |
| 132 | Protuberant abdomen (HP:0001538) | 1.93949126 |
| 133 | Steatorrhea (HP:0002570) | 1.93863160 |
| 134 | * Late onset (HP:0003584) | 1.92720439 |
| 135 | Chronic diarrhea (HP:0002028) | 1.91619141 |
| 136 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.90492191 |
| 137 | True hermaphroditism (HP:0010459) | 1.90413364 |
| 138 | Tubulointerstitial abnormality (HP:0001969) | 1.88023219 |
| 139 | Abnormality of macular pigmentation (HP:0008002) | 1.87500482 |
| 140 | Decreased central vision (HP:0007663) | 1.85983166 |
| 141 | Stomach cancer (HP:0012126) | 1.82462495 |
| 142 | Osteomalacia (HP:0002749) | 1.82360966 |
| 143 | Methylmalonic aciduria (HP:0012120) | 1.82072384 |
| 144 | Renal cortical cysts (HP:0000803) | 1.81500787 |
| 145 | Amelogenesis imperfecta (HP:0000705) | 1.80556180 |
| 146 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.79146188 |
| 147 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.77257291 |
| 148 | Congenital stationary night blindness (HP:0007642) | 1.74066044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 6.88880859 |
| 2 | WNK3 | 5.77155334 |
| 3 | BCKDK | 4.25941026 |
| 4 | OXSR1 | 4.23371909 |
| 5 | ERN1 | 3.16150607 |
| 6 | GRK1 | 2.86002432 |
| 7 | FRK | 2.74016977 |
| 8 | FGFR4 | 2.62814928 |
| 9 | MST1R | 2.48771825 |
| 10 | STK39 | 2.48622656 |
| 11 | INSRR | 2.35985297 |
| 12 | MAPK15 | 2.33065682 |
| 13 | STK38L | 2.27403264 |
| 14 | MAP3K9 | 1.83944760 |
| 15 | TAOK3 | 1.81859061 |
| 16 | TLK1 | 1.81187771 |
| 17 | ADRBK2 | 1.74508696 |
| 18 | PTK6 | 1.71671662 |
| 19 | STK24 | 1.60781642 |
| 20 | TRIB3 | 1.59901603 |
| 21 | EPHA2 | 1.57708842 |
| 22 | TNIK | 1.57510114 |
| 23 | ACVR1B | 1.55724557 |
| 24 | PTK2 | 1.52684512 |
| 25 | PDK3 | 1.44892716 |
| 26 | PDK4 | 1.44892716 |
| 27 | MST4 | 1.43705708 |
| 28 | SIK1 | 1.38619915 |
| 29 | DAPK2 | 1.35474510 |
| 30 | MET | 1.34516054 |
| 31 | MAP3K12 | 1.33790708 |
| 32 | EPHB1 | 1.33255127 |
| 33 | DYRK1B | 1.32793604 |
| 34 | PIK3CA | 1.25188549 |
| 35 | SGK494 | 1.24462296 |
| 36 | SGK223 | 1.24462296 |
| 37 | BMPR1B | 1.24333367 |
| 38 | LATS1 | 1.24137583 |
| 39 | MAP3K3 | 1.23821572 |
| 40 | IKBKB | 1.22438019 |
| 41 | MAPKAPK3 | 1.21381781 |
| 42 | ZAK | 1.19745989 |
| 43 | AKT3 | 1.11938493 |
| 44 | PRKCE | 1.11432053 |
| 45 | WNK1 | 1.10194231 |
| 46 | ERBB4 | 1.09241023 |
| 47 | MAP3K2 | 1.04634991 |
| 48 | LRRK2 | 1.04538863 |
| 49 | MAP2K2 | 1.03881426 |
| 50 | PAK4 | 1.02815141 |
| 51 | PRKCQ | 1.02807732 |
| 52 | RIPK1 | 1.00176313 |
| 53 | TRPM7 | 0.99986165 |
| 54 | NEK1 | 0.99769450 |
| 55 | BCR | 0.95445304 |
| 56 | SGK3 | 0.92384935 |
| 57 | PIK3CG | 0.91283344 |
| 58 | STK38 | 0.87361317 |
| 59 | GSK3A | 0.85317746 |
| 60 | FER | 0.85302376 |
| 61 | MAP3K10 | 0.82507230 |
| 62 | PASK | 0.81756388 |
| 63 | PDK2 | 0.80190624 |
| 64 | MAP3K7 | 0.79918913 |
| 65 | MAP4K2 | 0.79710019 |
| 66 | IRAK3 | 0.77348898 |
| 67 | MUSK | 0.75587473 |
| 68 | PRKCI | 0.73977770 |
| 69 | SGK2 | 0.72312615 |
| 70 | PNCK | 0.71116068 |
| 71 | LMTK2 | 0.68126367 |
| 72 | MAPK11 | 0.64440141 |
| 73 | IRAK1 | 0.62509772 |
| 74 | NUAK1 | 0.60706844 |
| 75 | EPHA3 | 0.59980804 |
| 76 | NME1 | 0.57700230 |
| 77 | GRK6 | 0.56798656 |
| 78 | PDGFRA | 0.54935700 |
| 79 | FGFR2 | 0.54897423 |
| 80 | PRKAA2 | 0.53823285 |
| 81 | PKN2 | 0.53375077 |
| 82 | PAK3 | 0.51742561 |
| 83 | CSF1R | 0.51612349 |
| 84 | FLT3 | 0.50367516 |
| 85 | MAP2K3 | 0.49482389 |
| 86 | NEK2 | 0.49168604 |
| 87 | PHKG2 | 0.48989706 |
| 88 | PHKG1 | 0.48989706 |
| 89 | PDPK1 | 0.48862614 |
| 90 | MAP2K6 | 0.47136544 |
| 91 | CDK9 | 0.47013142 |
| 92 | PRKAA1 | 0.46586057 |
| 93 | STK10 | 0.46353936 |
| 94 | PRKCZ | 0.45795355 |
| 95 | PRKD2 | 0.45709727 |
| 96 | MTOR | 0.45682289 |
| 97 | TGFBR2 | 0.45077035 |
| 98 | MAP3K14 | 0.45040150 |
| 99 | NLK | 0.44505851 |
| 100 | TESK1 | 0.44442114 |
| 101 | CAMK1G | 0.42097595 |
| 102 | PRKD3 | 0.41642853 |
| 103 | MAP2K1 | 0.41394720 |
| 104 | NEK9 | 0.41298503 |
| 105 | BRSK2 | 0.40464830 |
| 106 | MAP3K1 | 0.39987260 |
| 107 | MYLK | 0.39019419 |
| 108 | CSNK1A1 | 0.38939085 |
| 109 | PRKG2 | 0.38936057 |
| 110 | ROCK1 | 0.38339986 |
| 111 | DAPK3 | 0.38330571 |
| 112 | MAP4K1 | 0.38214686 |
| 113 | NTRK1 | 0.37536868 |
| 114 | MAPK7 | 0.35065255 |
| 115 | JAK2 | 0.34432109 |
| 116 | PRKCA | 0.34114412 |
| 117 | ABL2 | 0.34080689 |
| 118 | ERBB2 | 0.33655281 |
| 119 | MATK | 0.33186500 |
| 120 | TAOK2 | 0.32929723 |
| 121 | CSK | 0.32306946 |
| 122 | TBK1 | 0.32252927 |
| 123 | MAP3K11 | 0.31080436 |
| 124 | MELK | 0.30874310 |
| 125 | IRAK4 | 0.28807729 |
| 126 | PRKCH | 0.28722774 |
| 127 | JAK1 | 0.28519583 |
| 128 | IGF1R | 0.28317116 |
| 129 | MAP3K8 | 0.27776708 |
| 130 | DAPK1 | 0.27442941 |
| 131 | TIE1 | 0.27137251 |
| 132 | STK3 | 0.25757141 |
| 133 | PRKACG | 0.25405887 |
| 134 | CHUK | 0.25302369 |
| 135 | SGK1 | 0.25258139 |
| 136 | EIF2AK3 | 0.25147823 |
| 137 | BMX | 0.24937033 |
| 138 | PINK1 | 0.24180670 |
| 139 | VRK1 | 0.23995834 |
| 140 | FGFR1 | 0.22425900 |
| 141 | ZAP70 | 0.20949640 |
| 142 | TYK2 | 0.20483454 |
| 143 | EPHB2 | 0.19684798 |
| 144 | HIPK2 | 0.19391721 |
| 145 | FGFR3 | 0.18863014 |
| 146 | KSR2 | 0.18691323 |
| 147 | SCYL2 | 0.18542724 |
| 148 | PDK1 | 0.18532712 |
| 149 | PTK2B | 0.17371536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.47946006 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.99703104 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.91886249 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.90852803 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71295787 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.69221111 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.65393694 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.62868146 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52854940 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.49933971 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.49752859 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.43936145 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.38872168 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35499412 |
| 15 | * Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.33264640 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.30874251 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.29208609 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.27025108 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.21423935 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.05344420 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.01100569 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.95973182 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.90487278 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.89566387 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.87837541 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75126031 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.72120590 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.71880723 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71012762 |
| 30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.69442613 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.65189322 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63947491 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58857478 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48591081 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40745775 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36959725 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36083516 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.34621582 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.30107607 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29726518 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 1.26660783 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26008747 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.24259306 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.22933574 |
| 45 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.22634702 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.19973261 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18442993 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.17728599 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17220585 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 1.17119714 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16920676 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13148626 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09045959 |
| 54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.07023669 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04978808 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03819545 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02461583 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00443257 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99517689 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95362897 |
| 61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89701351 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.86555921 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.84032936 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.83977898 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.83081049 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82244637 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81431084 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.77984110 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77887625 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 0.76090610 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74749310 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68044114 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65848936 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65445947 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64499792 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.64234517 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62579968 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61931369 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57440229 |
| 80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.56946908 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55136826 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53846227 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53518527 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53391651 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52178771 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51560032 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51409997 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51362512 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50062863 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48870150 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44018916 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42223872 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41588501 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41331345 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.40645146 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38990475 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37619779 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35649908 |
| 99 | Protein export_Homo sapiens_hsa03060 | 0.34139821 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33676953 |
| 101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32000716 |
| 102 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31606644 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.31398164 |
| 104 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31177238 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.30298738 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29899104 |
| 107 | Insulin secretion_Homo sapiens_hsa04911 | 0.29581770 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29537662 |
| 109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.29221206 |
| 110 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.26331169 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.24903169 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.24082825 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.17335619 |
| 114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.14914062 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13294686 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11933676 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.07830059 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06657467 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.05246780 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.04195371 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03573394 |
| 122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.01820636 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.00186568 |
| 124 | Tight junction_Homo sapiens_hsa04530 | -0.0143718 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0115371 |

